Intrinseque Health wins Singapore clinical supply chain award for fifth straight year

By AI, Created 5:27 PM UTC, May 18, 2026, /AGP/ – Intrinseque Health has been named Best Clinical Supply Chain Solutions Provider 2026 Singapore, marking its fifth consecutive win. The award underscores the company’s role in global clinical trial logistics as drug development teams face tighter demands on sourcing, storage and delivery.

Why it matters: - The award signals continued recognition for Intrinseque Health in a niche but critical part of drug development. - Clinical supply chain failures can delay trials, increase costs and disrupt patient access to study materials. - The repeat win suggests the company has built a durable position in Singapore’s clinical development market.

What happened: - Intrinseque Health won Best Clinical Supply Chain Solutions Provider 2026 Singapore. - The recognition came from Global Health & Pharma’s awards program. - The company said the honor marks its fifth straight win in the category. - Nitin Jain, president and CEO of Intrinseque Health, said the award reflects the company’s work on clinical development supply chain solutions.

The details: - Intrinseque Health provides clinical development support services for global clinical trial studies. - The company is certified under EN ISO 13485, ISO 9001, ISO 27001 and GDPMDS. - Intrinseque Health operates offices in the United States, the Netherlands, the United Kingdom, China, Taiwan, Korea, India, Malaysia and Singapore. - The company says its team is led by drug development professionals with more than 300 years of combined experience supporting clinical trials across therapeutic areas. - Core services include product availability planning, lead-time management, in-country sourcing versus import decisions, import regulations, IOR/EOR requirements, storage and warehousing, kitting, labeling, printing, installation, calibration, validation, servicing, maintenance, local sourcing and procurement. - Intrinseque Health says it engages early with clients and uses a cost-effective supply chain strategy tailored to each clinical trial. - The company says it aims to become a global leader in clinical trial support services.

Between the lines: - The repeat award suggests buyers and industry groups may value execution, reliability and regulatory know-how as much as pricing. - Intrinseque Health is positioning itself as a specialist in the operational details that can make or break a trial timeline. - The company’s emphasis on quality, sourcing flexibility and “every time” delivery points to a pitch centered on risk reduction.

What’s next: - Intrinseque Health is likely to keep expanding its clinical trial support footprint across its international offices. - The company will continue competing for global clinical supply chain business as trials grow more complex. - Jain framed ongoing innovation and service expansion as central to the company’s next phase.